[1] Rebalanced hemostasis in liver disease has, for example, been demonstrated by a normal to increased thrombin generation capacity using thrombomodulin-modified calibrated automated thrombinography, including the activation of anticoagulant pathways by the addition of thrombomodulin. This evidence concerns the gene THBD and liver disorder.